Older Patients of epilepsy more likely to develop cardiovascular events: JAMA
A new study published in the recent edition of Journal of American Medical Association suggests that when providing enzyme-inducing antiseizure medications (EIASMs) to elderly patients who have epilepsy, doctors should use caution if there are additional cardiovascular risk factors present.
In their lifetime, one in 10 persons will experience at least one epileptic episode. Although epilepsy frequently strikes younger people, adults 60 years of age and beyond account for the majority of persons with epilepsy (PWE), both new onset and long-standing. There is a robust cross-sectional correlation between cardiovascular disease (CVD) and epilepsy. Also, a number of studies have demonstrated that there is a significant risk of developing cerebrovascular disease even in individuals whose epilepsy is not caused by it. Thereby, Jimmy Li and his team conducted this study to investigate the probabilities of new-onset cardiovascular events (CVEs) in patients with and without epilepsy during a 6-year period. Also, the mediation effects of EIASM usage and conventional cardiovascular risk factors (CVRFs) on this connection was investigated, with the goal of determining respective contribution of each factor to CVD risk in epilepsy.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.